Evidence behind common 5-Amino-1MQ benefit claims Claimed outcome Fat-mass changes Evidence level Animal evidence What research currently shows Obese mouse studies reported less body-weight gain, lower fat mass, or smaller fat cells after NNMT inhibition
Gastrointestinal adverse events (nausea, diarrhea, constipation) were the most common side effects in Phase 2, consistent with the GLP-1 class
Ozempic is FDA-approved for the treatment of type 2 diabetes, to improve blood sugar, along with diet and exercise, and reduce the risk of major cardiovascular events such as heart attack, stroke or death in adults with type 2 diabetes and known heart disease, according to the company
The trade-off is real, and the regulatory floor sits lower
Months 4 to 6: Steady Progress Dose climbs to 1.7 milligrams at week 13, then 2.4 milligrams at week 17
While GLP-1 receptors are expressed in hypothalamic and reproductive pathways, human data do not demonstrate direct infertility effects